AI assistant
Sending…
Cryoport, Inc. — Director's Dealing 2025
Aug 21, 2025
32876_dirs_2025-08-21_b3c533fa-a05c-4540-91f2-cb61322c605a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2025-08-19
Reporting Person: STEFANOVICH ROBERT (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-19 | Common Stock | M | 26164 | $3.07 | Acquired | 216513 | Direct |
| 2025-08-19 | Common Stock | S | 9300 | $8.6686 | Disposed | 207213 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-19 | Options to purchase common stock | $3.07 | M | 26164 | Disposed | 2025-08-20 | Common Stock (26164) | Direct |
Footnotes
F1: The proceeds of the sale of Common Stock were used to pay the exercise price due upon the exercise of the Stock Option reported in this Form 4.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.60 to $8.75, inclusive.
F3: 1/48 of the options vested on the 20th of each month for forty-eight months beginning on August 19, 2015.
More from Cryoport, Inc.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18